NCT01475266 Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Status TERMINATED Phase PHASE2/PHASE3
NCT01469221 Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Status TERMINATED Phase PHASE3
NCT01459653 Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor Status COMPLETED Phase N/A
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) Status UNKNOWN Phase N/A
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia Status COMPLETED Phase N/A
NCT01442519 Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer Status COMPLETED Phase PHASE3
NCT01438112 Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT01426126 Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum Status COMPLETED Phase PHASE2
NCT01410565 Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer Status TERMINATED Phase PHASE3
NCT01395225 Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer Status COMPLETED Phase N/A
NCT01373398 Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) Status COMPLETED Phase PHASE1
NCT01373294 Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer Status COMPLETED Phase PHASE2
NCT01343121 Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy Status COMPLETED Phase NA
NCT01339000 Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy Status TERMINATED Phase PHASE2
NCT01331824 Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT01316874 Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) Status COMPLETED Phase PHASE2/PHASE3
NCT01314664 A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC) Status TERMINATED Phase N/A
NCT01284348 To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2